- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
STAT3-mediated osteogenesis and osteoclastogenesis in osteoporosis ; volume:20 ; number:1 ; day:25 ; month:7 ; year:2022 ; pages:1-17 ; date:12.2022
Cell communication and signaling ; 20, Heft 1 (25.7.2022), 1-17, 12.2022
- Urheber
-
Hou, Xiaoli
Tian, Faming
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-022-00924-1
- URN
-
urn:nbn:de:101:1-2022100619534321302676
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hou, Xiaoli
- Tian, Faming
- SpringerLink (Online service)
Ähnliche Objekte (12)
TRPA1 aggravates osteoclastogenesis and osteoporosis through activating endoplasmic reticulum stress mediated by SRXN1
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis
DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis
SETD2-mediated epigenetic regulation of noncanonical Wnt5A during osteoclastogenesis
Elucidating the role of RBM5 in osteoclastogenesis: a novel potential therapeutic target for osteoporosis
Unique expression and critical role of metallothionein 3 in the control of osteoclastogenesis and osteoporosis
TRPA1 aggravates osteoclastogenesis and osteoporosis through activating endoplasmic reticulum stress mediated by SRXN1
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis
DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis
SETD2-mediated epigenetic regulation of noncanonical Wnt5A during osteoclastogenesis
Elucidating the role of RBM5 in osteoclastogenesis: a novel potential therapeutic target for osteoporosis
Unique expression and critical role of metallothionein 3 in the control of osteoclastogenesis and osteoporosis
TRPA1 aggravates osteoclastogenesis and osteoporosis through activating endoplasmic reticulum stress mediated by SRXN1
The role of LncRNAs and CircRNAs in osteoporosis: a focus on osteogenesis and osteoclastogenesis signaling pathways
The histone methyltransferase DOT1L inhibits osteoclastogenesis and protects against osteoporosis
DZNep promotes mouse bone defect healing via enhancing both osteogenesis and osteoclastogenesis
NLRC3 attenuates osteoclastogenesis by limiting TNFα+ Th17 cell response in osteoporosis
Aspirin prevents estrogen deficiency-induced bone loss by inhibiting osteoclastogenesis and promoting osteogenesis
Complement receptor C5aR1 on osteoblasts regulates osteoclastogenesis in experimental postmenopausal osteoporosis
Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy
Intramedullary injury combined with osteoporosis therapeutics regulates targeted local osteogenesis
SETD2-mediated epigenetic regulation of noncanonical Wnt5A during osteoclastogenesis
Elucidating the role of RBM5 in osteoclastogenesis: a novel potential therapeutic target for osteoporosis